Lokelma for RAAS Maximisation in CKD & Heart Failure.

NCT05004363 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

112

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Diseases
Heart Failure With Reduced Ejection Fraction
Hyperkalemia
ACE Inhibitor Induced Hyperkalaemia
Mineralocorticoid Resistant Hyperkalemia

Interventions

DRUG: Lokelma Oral Product

Sponsor

St George's, University of London